Abstract
Background
Conventional approaches (CA) include the posterior approach (PA) and the lateral approach (LA). Although the direct anterior approach (DAA) and CA possess distinct advantages and limitations in clinical treatment outcomes, the existing literature provides conflicting descriptions. Therefore, this study conducted a systematic literature review and meta-analysis based on randomized clinical trials (RCTs) to compare the clinical outcomes of DAA and CA in total hip replacement (THR).
Methods
Up to May 2025, we executed a comprehensive literature search to compare RCTs of DAA and CA in THA. We assessed Surgical parameters, functional scores, and postoperative complications. Pooled statistical analysis was employed to quantify the therapeutic outcomes by comparing DAA and CA, with CA as the control group, using data extracted from the included RCTs. We used the Review Manager 5.4 software for assessing publication bias and data analysis, and I² (based on the DerSimonian-Laird method) to assess the heterogeneity among studies. We used the random-effects model for the pooled analysis.
Results
This study included 17 eligible RCTs comprising 1,575 patients, of which 4 were Level I evidence and 13 were Level II evidence. The meta-analysis revealed that DAA prolonged the operative time (random-effects model, mean difference [MD] = 14.5 min, 95% confidence interval [CI] 9.14 to 19.86, p < 0.01), resulted in lower posteroperative day 1 pain scores (random-effects model MD = -0.79, 95% CI -1.00 to -0.59, p < 0.01), demonstrated superior early functional outcomes (Harris Hip Score at 1 month postoperatively, random-effects model, MD = 3.41, 95% CI 0.29 to 6.53, p = 0.03), and was linked to an increased risk of postoperative nerve injury (relative risk [RR] = 7.37, 95% CI 2.52 to 21.51, p < 0.01). No comparable outcomes were found between DAA and CA methods in intraoperative blood loss, VAS score at 1 month postoperatively, Harris score after 3 months, and other complications (intraoperative fracture, intraoperative greater trochanter fracture, dislocation, infection, wound complications, thrombosis, etc.)..
Conclusion
Compared with CA, DAA reduced early postoperative pain levels and yielded superior early hip joint function. However, DAA was linked to longer operative durations and an elevated risk of nerve injury.
Keywords: Direct anterior approach, Posterior approach, Lateral approach, Complications, Efficacy
Graphical Abstract
Introduction
Total hip arthroplasty (THA) provides good outcomes and longevity, since Charnley [1] introduced the modern concepts with sound principles of biomechanics. Surgeons strive to reduce complications by employing good surgical techniques, with different surgical approaches giving rise to differential challenges. Conventional surgical techniques for hip replacement encompass the posterior approach (PA) and the lateral approach (LA). The PA exposes the hip joint by dissecting the external rotator muscle group and the gluteus maximus tendon [2, 3]. The LA requires splitting the gluteus medius and minimus muscles [4, 5]. Both the PA and LA require muscle dissection, which results in muscle damage, causing early postoperative pain. The anterolateral approach, which enters the hip joint via the intermuscular plane between the gluteus medius and tensor fasciae latae, was not included in the CA. As an intermuscular approach, the direct anterior approach (DAA) was first proposed by Carl Hueter [6]. It gradually became popular with the use of a dedicated operating Tables [7, 8]. Clinical research on DAA focused on the management of complications and how to shorten the learning curve [9]. At the same time, the utility of the DAA expanded and was no longer limited to primary total hip arthroplasty, extending to include complex hip revision surgeries [10]. Although the popularity in the Asian region is relatively low, it is growing [11, 12]. Existing meta-analyses have conflicting descriptions regarding the early functional outcomes of DAA compared to traditional approaches. Some studies suggest that DAA has superior early functional outcomes [13–15], while others indicate that the two approaches are similar [16, 17]. Additionally, the existing meta-analyses failed to compare these outcomes against surgical complications, hence lacking in-depth analysis of the common complications [18–21]. This study aims to evaluate the comparative clinical outcomes of DAA and CA for hip disorders or injuries, restricted to high-level RCT evidence.
Methods
Reporting and registration
This study followed PRISMA-P guidelines. The study protocol was registered prospectively with PROSPERO on June 7, 2025, and was approved on June 8, 2025. The registration number is CRD420251069424.
Data sources and search strategy
The Electronic databases used for the search included PubMed, EMBASE, Web of Science, and the Cochrane Library. The search was conducted up to June 2025. The keywords used were: (1) “direct anterior approach” OR “DAA”; (2) “posterior approach” OR “PA”; (3) “lateral approach” OR “LA”; (4) “total hip replacement.” The search strategy was “(1) AND (2) AND (4)” OR “(1) AND (3) AND (4).” The search strategy was ((((posterior approach) OR (PA)) AND ((direct anterior approach) OR (DAA))) AND ((total hip replacement) OR (THA))) OR ((((lateral approach) OR (LA)) AND ((direct anterior approach) OR (DAA))) AND ((total hip replacement) OR (THA))). A total of 1,976 articles were retrieved, including 674 from PubMed, 313 from EMBASE, 872 from Web of Science, and 108 from Cochrane Library.
Study screening and selection
Titles and abstracts were screened independently by two reviewers for preliminary identification of relevant articles for full-text review. After screening the full texts of the remaining articles, the two reviewers again assessed to determine inclusion. Final inclusion determinations were reached jointly by both reviewers, with arbitration by a third reviewer in cases of disagreement. The screening process was applied independently to studies on DAA and CA, using the same method.
Inclusion criteria
(1) Randomized controlled trials (RCTs); (2) Patients with hip joint diseases or hip fractures; (3) Comparative studies evaluating DAA and CA; (4) Control groups included posterior or posterolateral approaches, direct lateral, or lateral approaches. Exclusion Criteria: (1) Lack of outcome measures of interest or incomplete data; (2) Minimally invasive small-incision approaches; (3) Use of computer navigation systems; (4) Hemiarthroplasty; (5) Anterolateral approach.
Data extraction and analysis
Two independent reviewers extracted data. Discrepancies were resolved through discussion, through consensus, or consultation with a third reviewer. Relevant data were extracted into Excel spreadsheets. Extracted data items included: first author, publication year, country, sample size, baseline patient characteristics, and target indicators.
Risk of bias and level of evidence
The risk of bias for included studies was assessed using the Cochrane Risk of Bias tool.
Statistical analysis
EndNote 21.5 software was used for literature management, Excel for data collection and extraction, and Review Manager 5.4 software for meta-analysis. Heterogeneity among studies was evaluated using the I2 statistic (based on the DerSimonian-Laird method). The random-effects model was used for the pooled analysis. Continuous outcomes were presented as mean differences (MD) with 95% confidence intervals (CI) were used to describe the data, and forest plots were generated to display the results. Sensitivity analyses were performed to examine the stability of the results. Funnel plots were generated to evaluate potential publication bias risk. Statistical significance was defined as p < 0.05 (two-sided).
Results
The study selection followed the details in the PRISMA flow diagram (Fig. 1). The completed PRISMA checklist is provided as a supplementary file. Following the removal of 750 duplicate articles, an initial screening identified 1,217 articles. After screening titles and abstracts, 57 articles were retained for full-text evaluation. After full-text reading and analysis, 17 RCTs were finally included, of which two were published in Chinese and 15 in English, published between 2013 and 2025, collectively enrolling 1,575 patients, with 785 patients receiving DAA and 790 patients receiving CA (320 patients with LA, 470 patients with PA), with sample sizes ranging from 46 to 164.
Fig. 1.
PRISMA flow diagram
Characteristics of the RCTs
A total of 17 RCTs comparing DAA and CA were included, involving 1,575 patients, as shown in the table. Primary preoperative indications included osteoarthritis, femoral neck fractures, and femoral head avascular necrosis.
Risk of bias and level of evidence
Study quality was appraised using the Cochrane risk of bias tool (Fig. 2). A summary of the assessment is presented in Table 1. Among the 17 studies, 4 were blinded RCTs, classified as Level Ⅰ evidence. The remaining 13 were non-blinded RCTs, categorized as Level Ⅱ evidence.
Fig. 2.
Risk of Bias assessment graph
Table 1.
Showed the authors, years, country, sample sizes, and basic characteristics of the samples of the included articles
| study | country | Sample size, n | Surgical approach | Mean Age, y(SD) | Gender (M/F), n | BMI, kg/m2(SD) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| DA | CA | DA | CA | DA | CA | DA | CA | |||
| Barrett, 2013 [22] | American | 87 | 43 | 44(PA) | 61.4 ± 9.2 | 63.2 ± 7.7 | 29/14 | 19/25 | 30.7 ± 5.4 | 29.1 ± 5 |
| Rodriguez, 2014 [23] | American | 120 | 60 | 60(PA) | 60 ± 10 | 59 ± 6 | 28/32 | 26/34 | 27 ± 4 | 28 ± 4 |
| Christensen, 2015 [24] | American | 51 | 28 | 23(PA) | 64.3 ± 9.1 | 65.2 ± 9.1 | 13/15 | 11/12 | 31.1 ± 5.1 | 30.4 ± 3.6 |
| De Anta-Diaz, 2016 [25] | Spain | 99 | 50 | 49(LA) | 64.8 ± 10.1 | 63.5 ± 12.5 | 26/24 | 26/23 | 26.6 ± 3.9 | 26.9 ± 3.1 |
| Luo, 2016 [26] | China | 104 | 52 | 52(PA) | 61.5 ± 7.2 | 63.7 ± 6.8 | 17/35 | 22/30 | 22.7 ± 4.4 | 24.1 ± 3.7 |
| Rykov, 2017 [27] | Netherlands | 46 | 23 | 23(PA) | 62.8 ± 6.1 | 60.2 ± 8.1 | 8/15 | 11/12 | 29 ± 5.6 | 29.3 ± 4.8 |
| Zhao, 2017 [28] | China | 120 | 60 | 60(PA) | 64.88 ± 12.13 | 62.18 ± 14.72 | 24/36 | 26/34 | 24.35 ± 3.1 | 25.58 ± 2.83 |
| Zomar, 2018 [29] | London | 78 | 36 | 42(LA) | 60.78 ± 9.26 | 59.54 ± 8.4 | 21/15 | 20/22 | 28.38 ± 4.51 | 30.89 ± 5.43 |
| Bon, 2019 [30] | France | 100 | 50 | 50(PA) | 67.26 ± 10 | 68.98 ± 7.93 | 21/29 | 23/27 | 26.46 ± 3.58 | 26.69 ± 3.12 |
| Mjaaland, 2019 [31] | Norway | 164 | 84 | 80(LA) | 67 ± 9 | 66 ± 9 | 25/59 | 30/50 | 28 ± 4 | 28 ± 4 |
| Moerenhout, 2020 [32] | Canada | 55 | 28 | 27(PA) | 70.4 ± 9.1 | 68.9 ± 8.8 | 11/17 | 18/9 | 27.6 ± 4.4 | 26.5 ± 4.3 |
| Cao, 2020 [33] | China | 130 | 65 | 65(PA) | 61.4 ± 12.8 | 62.4 ± 8.3 | 27/38 | 28/37 | 24.7 ± 1.9 | 25.1 ± 1.8 |
| Iorio, 2021 [34] | Italy | 60 | 29 | 31(LA) | 62.7 ± 4.9 | 67.2 ± 8.8 | 14/15 | 17/14 | 28.7 ± 3.4 | 29.9 ± 3.1 |
| Nambiar, 2021 [35] | Australia | 52 | 23 | 29(PA) | 64 ± 11 | 66 ± 10 | 11/12 | 13/16 | 27 ± 3 | 28 ± 4 |
| Zhang, 2021 [36] | China | 128 | 62 | 66(PA) | 61.7 ± 7.1 | 63.3 ± 8.2 | 35/27 | 40/26 | 24.6 ± 3 | 25 ± 3.4 |
| Yunchun, 2024 [37] | China | 51 | 28 | 23(PA) | 65.26 ± 5.89 | 64.47 ± 5.12 | 10/18 | 11/12 | 23.45 ± 3.12 | 24.03 ± 3.3 |
| Hoseth, 2025 [38] | Norway | 130 | 64 | 66(LA) | 78.1 ± 1.2 | 79.1 ± 1.2 | 22/42 | 25/41 | 25 ± 0.6 | 23.8 ± 0.5 |
Clinical and statistical heterogeneity
In terms of baseline characteristics (including gender, age, and body mass index [BMI]), no clinically relevant baseline differences were found between the experimental group (DAA) and the control group (CA) patients (see Table 1). Statistical heterogeneity measures for all outcomes are presented in Figs. 3, 4, 5 and 6.
Fig. 3.
Displays the forest plots for VAS scores on the first postoperative day and at one month postoperatively
Fig. 4.
The forest plot shows the Harris hip scores at one month, three months, and one year postoperatively
Fig. 5.
The forest plot shows the complications, including periprosthetic infection and wound complications
Fig. 6.
The forest plot displays the complications, including dislocation rate, nerve injury, thrombosis, and revision rate within one year
Surgical outcomes (Figs. 3 and 7)
Fig. 7.
Displays the forest plots for operative time and blood loss
Operation time
In the analysis of DAA and CA, data from 822 patients in 9 RCTs were included (I² = 94%, p < 0.01, see Fig. 7). Using the random-effects model, DAA had a longer operative time by 14.5 min compared to CA (MD = 14.5, 95% CI 9.14 to 19.86, p < 0.01).
Blood loss
In the comparison of DAA versus CA, data from 311 patients in 3 RCTs were pooled (I² = 98%, p < 0.01, see Fig. 7). Using the random-effects model, intraoperative blood loss was comparable between groups (MD = 60.85, 95% CI -10.52 to 132.22, p = 0.09).
VAS 1 day postoperatively
In the evaluation of DAA versus CA, data from 337 patients in 3 RCTs were pooled (I² = 11%, p < 0.01, see Fig. 3). Using the random-effects model, DAA had a lower VAS score on postoperative Day 1 compared to CA (MD = -0.79, 95% CI -1.00 to -0.59, p < 0.01).
At 1 month postoperatively, comparing DAA and CA yielded pooled data from 454 patients in 5 RCTs, which were pooled (I² = 94%, p < 0.01, see Fig. 3). Using the random-effects model, there was no difference in postoperative VAS scores at 1month (MD = -0.14, 95% CI -0.74 to 0.45, p = 0.64).
Functional outcomes (Fig. 4)
Harris 1 month
In the assessment of DAA and CA, data from 483 patients in 5 RCTs were combined (I² = 75%, p < 0.01, see Fig. 4). Using the random-effects model, DAA had a higher Harris score at 1 month post-surgery compared to CA (MD = 3.41, 95% CI 0.29 to 6.53, p = 0.03).
Harris 3 months
In the analysis of DAA versus CA, data from 789 patients in 8 RCTs were pooled (I² = 92%, p < 0.01, see Fig. 4). Using the random-effects model, Harris score were comparable at 3 months (MD = 1.73, 95% CI -0.17 to 3.64, p = 0.07).
Harris 1 year
In the comparison between DAA and CA, data from 489 patients in 5 RCTs (I² = 0%, p = 0.72, see Fig. 4). Using the random-effects model, no significant difference was observed in the Harris score at 1 year postoperatively (MD = -0.3, 95% CI -1.36 to 1.96, p = 0.72).
Complications outcomes (Figs. 5, 6 and 8)
Fig. 8.
The forest plot displays the complications, including intraoperative fractures and greater trochanter fractures
Periprosthetic joint infection
In the comparison between DAA and CA, data from 285 patients in 3 RCTs (I²= 0%, p = 0.7, see Fig. 5). Using the random-effects model, the incidence of periprosthetic joint infection was comparable between groups (RR = 0.70, 95% CI 0.11 to 4.35, p = 0.70).
Wound complications
In the comparison between DAA and CA, data from 381 patients in 3 RCTs (I2 = 0%, p = 0.61, see Fig. 5). Using the random-effects model, there was no difference in wound complication incidence (RR = 0.99, 95% CI 0.17 to 5.67, p = 1.00).
Dislocation
In the comparison between DAA and CA, data from 799 patients in 7 RCTs were pooled (I² = 0%, p = 0.34, see Fig. 6). Using the random-effects model, dislocation rates were similar (RR = 0.58, 95% CI 0.19 to 1.78, p = 0.34).
Nerve injury
In the comparison between DAA and CA, data from 858 patients in 8 RCTs were pooled (I² = 14%, p = 0.32, see Fig. 6). Using the random-effects model, DAA demonstrated a significantly increased risk of nerve injury relative to CA (RR = 7.37, 95% CI 2.52 to 21.51, p < 0.01).
Thrombus formation
In the comparison between DAA and CA, data from 466 patients in 4 RCTs were combined (I² = 0%, p = 0.96, see Fig. 6). Using the random-effects model, the incidence of lower limb thrombosis was similar (RR = 1.04, 95% CI 0.24 to 4.50, p = 0.96).
Revision within 1 year
In the comparison between DAA and CA, data from 337 patients in 3 RCTs were pooled (I² = 0%, p = 0.55, see Fig. 6). Using the random-effects model, no significant difference in revision rates within 1 year (RR = 0.79, 95% CI 0.15 to 4.06, p = 0.78).
Intraoperative fracture
In the assessment of DAA and CA, data from 754 patients in 7 RCTs were included (I²= 0%, P = 0.76, see Fig. 8). Using the random-effects model, there was no difference in intraoperative fracture incidence (RR = 1.24, 95% CI 0.39 to 3.97, p = 0.72).
Intraoperative greater trochanter fracture
In the comparison between DAA and CA, data from 404 patients in 3 RCTs were pooled (I² = 0%, p = 1.00, see Fig. 8). Using the random-effects model, although there was no statistical difference in the intraoperative greater trochanteric fracture rate (RR = 2.95, 95% CI 0.47 to 18.54, p = 0.25), the aggregated data suggested a consistent upward trend in the incidence of greater trochanteric fractures during DAA across different studies.
Discussion
The advancement in surgical techniques for total hip arthroplasty is reflected in artificial intelligence applications [39, 40] and the improvement of surgical approaches. In this study, a quantitative analysis of the efficacy of DAA compared to CA in THA was performed. We examined surgical time, intraoperative blood loss, postoperative pain levels, functional scores, and postoperative complications (intraoperative fracture, intraoperative greater trochanter fracture, dislocation, infection, wound complications, thrombosis, etc.) to evaluate the relative risks and benefits of each approach.
Our pooled analysis demonstrated that patients undergoing DAA required longer operative times compared to the control group (MD = 14.5 min, 95% CI 9.14 to 19.86, p < 0.01). The results are similar to those of previously published meta-analyses [20]. The DAA has a steep learning curve, which can lead to prolonged surgical time, and the surgical outcomes stabilized after 100 cases [41, 42]. In the 9 studies included in this meta-analysis, 5 studies declared that the surgeons had completed at least 100 DAAs before starting the study, and the remaining four studies all declared that the surgeons were experienced experts with stable skills. Therefore, this suggests that an average increase in surgical time of 14.5 min still exists even when the surgery is performed by experienced experts. The DAA group reported significantly less severe postoperative pain on day 1 (VAS MD = -0.79, 95% CI -1.00 to -0.59, p < 0.01), and better early function (Harris hip score at 1 month postoperatively, MD = 3.41, 95% CI 0.29 to 6.53, p = 0.03). The DAA is associated with less postoperative pain and faster functional recovery, which reduces patients’ length of hospital stay and economic burden [43]. However, this also poses challenges to rehabilitation centers. Studies have shown that the probability of DAA patients being transferred to rehabilitation centers after surgery was significantly lower than that of patients who underwent the PA [44]. The advantages in pain and functional scores disappeared at 1 month (VAS at 1 month postoperatively, MD = -0.14, 95% CI -0.74 to 0.45, p = 0.64) and 3 months postoperatively (Harris score at 3 months, MD = 1.73, 95% CI -0.17 to 3.64, p = 0.07), respectively. The advantage in the Harris score also disappeared at 1 year postoperatively (MD = -0.3, 95% CI -1.36 to 1.96, p = 0.72). However, the DAA was associated with a significantly higher rate of postoperative nerve injury than CA (relative risk RR = 7.37, 95% CI 2.52 to 21.51, p < 0.01). This is a well-known and expected result based on the anatomical location of the lateral femoral cutaneous nerve. It is worth noting that this nerve is a sensory nerve, and such an injury is usually benign, with minimal impact on patient-reported outcomes and long-term function [45]. Statistically significant differences were not observed between groups for intraoperative blood loss and other complication rates.
Compared with previous studies, our study not only focused on pain perception and hip joint functional scores but also paid close attention to the incidence of postoperative complications, providing a more comprehensive assessment of the incidence of complications pertaining to both approaches.
In the meta-analysis of lower limb thrombosis formation, a total of 4 RCTs were included. In our research findings, there was no significant statistical difference between the DAA and the CA in this complication. However, none of the 4 studies explicitly described the postoperative anticoagulation regimen. It is worth noting that different doses of anticoagulation regimens can have varying effects on patients [46, 47], such as an increased risk of postoperative bleeding.
Although DAA has minimally invasive characteristics compared with CA, exposing the femoral side during surgery is one of the challenges. Some studies have suggested that insufficient femoral exposure may increase the risk of femoral fractures [48]. Jewett and Matta [49, 50] reported several cases of greater trochanter fractures occurring during femoral exposure using the DAA. However, Zhao Wang et al. [51] reported in a 2018 meta-analysis incorporating 9 RCTs totaling 754 THAs, comparing DAA with PA. The results showed comparable rates of intraoperative fractures between the two groups. This conflicting result is noteworthy. In our study, we not only compared the overall intraoperative fracture rates between DAA and CA but also specifically analyzed the incidence of greater trochanter fractures. The meta-analysis results showed no statistical differences between DAA and CA in either overall intraoperative fracture rates or greater trochanter fracture rates (Intraoperative fracture, RR = 1.16, 95% CI 0.43 to 3.15, p = 0.77; Intraoperative greater trochanter fracture, RR = 2.95, 95% CI 0.47 to 18.54, p = 0.25). The results were similar to the meta-analysis results reported by Miller et al. [52]. However, in this meta-analysis, a consistent upward trend in the incidence of greater trochanteric fractures was observed across different studies. The exposure of the femoral side is a surgical technique issue, which can be resolved by improving surgical skills. We should not attribute intraoperative fractures to the approach itself. Meanwhile, the increasing trend of greater trochanteric fractures also reminds surgeons to pay more attention to the exposure of the femoral side when performing DAA.
The incidence of periprosthetic joint infection and wound complications associated with the DAA has been a topic of discussion. The surgical incision for DAA is close to the inguinal area, where skin folds can accumulate, making it a relative contraindication for patients with high BMI. Harold I Salmons et al. [53] published a multicenter retrospective study in 2024, which included 17,111 patients, with 11,585 undergoing lateral-based approaches (including lateral and posterior approaches) and 5,526 undergoing DAA. The risk of wound complications was significantly elevated in DAA patients (3.6%) versus those receiving traditional approaches (2.6%). Connor, Acuña, et al. [54, 55] published 2 meta-analyses showing that DAA is not linked to an elevated risk of periprosthetic joint infection. In our study, we compared the incidence of these complications and the results showed no statistical differences between DAA and CA in either wound complications (RR = 0.99, 95% CI 0.17 to 5.67, p = 1.00) or periprosthetic joint infection (RR = 0.70, 95% CI 0.11 to 4.35, p = 0.70), In the 3 studies pooled for the analysis of PJI, the average BMI of all groups was less than 28 kg/m². Therefore, the results of this study can not be used to consider DAA for obese patients. In today’s literature, there are still limitations in the application of DAA among patients with higher BMI, and this study was not designed to challenge this view.
Since DAA preserves the posterior soft tissue structure, it is theoretically thought to reduce dislocation risk. John V. Horberg et al. [56] reviewed a non-selective consecutive cohort involving 2,205 patients with 2,831 hip joints. There were 11 dislocations (0.38%) within 1 year postoperatively, and a total of 13 dislocations (0.46%) at the final follow-up, indicating a low dislocation risk even in patients with instability risk factors. However, the PA, after technical modifications, posterior soft tissue reconstruction combined with modern large-diameter prosthetic heads, has significantly reduced the dislocation rate. Whether the DAA reduced dislocation risk compared to the PA remains inconclusive. A recent meta-analysis [57] demonstrated comparable dislocation rates between DAA and PA or LA. Similarly, in our study, dislocation rates did not differ statistically between DAA and CA (RR = 0.56, 95% CI 0.21 to 1.49, p = 0.24).
Several limitations warrant consideration. This study endeavored to include all complications following THA comprehensively, but due to the limited number of studies, certain complications, such as heterotopic ossification and pseudotumor formation [58], were not included. This study applied the DerSimonian-Laird method to assess heterogeneity, which carries the risk of producing overly optimistic results [59]. The relatively limited number of eligible studies may have contributed to substantial heterogeneity, potentially affecting the precision of the pooled estimates. There may also be unidentifiable confounding factors that could influence the results. For example, variations in patient populations, surgeon expertise, and operative techniques among the included studies may impact the outcomes. Such confounding factors may introduce bias into our results, and therefore, the study findings warrant cautious interpretation. Finally, the included studies exhibited heterogeneity in design, methodological quality, and reporting standards, introducing potential biases. Inconsistencies in outcome definitions and reporting, along with missing data, may affect the consistency and comparability of the results. Consequently, our results should be interpreted cautiously. Further research featuring larger cohorts, extended follow-up, and standardized outcome measures is required to validate these findings and enhance understanding of the comparative effectiveness and safety profiles of DAA and CA for THA .
Author contributions
RLand YHZ drafted the main manuscript, ZY was responsible for organizing the data, CCL, QS, XYN served as the three reviewers responsible for the selection of the included literature in this study.
Funding
This study was not supported by any funding.
Data availability
No datasets were generated or analysed during the current study.
Declarations
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Changcheng Liu, Email: liuchangcheng3022@hebmu.edu.cn.
Qi Sun, Email: 59003946@hebmu.edu.cn.
Xinyu Nan, Email: 19101797@hebmu.edu.cn.
References
- 1.Charnley J. Arthroplasty of the hip. A new operation. Lancet. 1961;1(7187):1129–32. 10.1016/s0140-6736(61)92063-3. [DOI] [PubMed] [Google Scholar]
- 2.Mehlman CT, Meiss L, DiPasquale TG. Hyphenated-history: the Kocher-Langenbeck surgical approach. J Orthop Trauma. 2000;14(1):60–4. 10.1097/00005131-200001000-00012. [DOI] [PubMed] [Google Scholar]
- 3.Moore AT. The self-locking metal hip prosthesis. J Bone Joint Surg Am. 1957;39–a(4):811–27. [PubMed]
- 4.Foster DE, Hunter JR. The direct lateral approach to the hip for arthroplasty. Advantages and complications. Orthopedics. 1987;10(2):274–80. 10.3928/0147-7447-19870201-06. [DOI] [PubMed] [Google Scholar]
- 5.Nissen KI. The judget arthroplasty of the hip via gibson’s lateral approach. Postgrad Med J. 1952;28(321):412–23. 10.1136/pgmj.28.321.412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Hernigou P. Smith-Petersen and early development of hip arthroplasty. Int Orthop. 2014;38(1):193–8. 10.1007/s00264-013-2080-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kennon R, Keggi J, Zatorski LE, Keggi KJ. Anterior approach for total hip arthroplasty: beyond the minimally invasive technique. J Bone Joint Surg Am. 2004;91–7. 10.2106/00004623-200412002-00013. 86-A Suppl 2. [DOI] [PubMed]
- 8.Matta JM, Ferguson TA. Total hip replacement after acetabular fracture. Orthopedics. 2005;28(9):959–60. 10.3928/0147-7447-20050901-23. [DOI] [PubMed] [Google Scholar]
- 9.Rivera F, Comba LC, Bardelli A. Direct anterior approach hip arthroplasty: how to reduce complications - A 10-years single center experience and literature review. World J Orthop. 2022;13(4):388–99. 10.5312/wjo.v13.i4.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Peters CJ, Dopson E, Ross JA, Goldman AH. A systematic review on revision total hip arthroplasty employing the direct anterior approach. Arch Orthop Trauma Surg. 2024;145(1):69. 10.1007/s00402-024-05727-2. [DOI] [PubMed] [Google Scholar]
- 11.Rietbergen L, Dooren BV, Zijlstra WP, et al. The rise of the direct anterior approach: trends, learning curves, and patient characteristics of 63,182 primary total hip arthroplasties in the Dutch arthroplasty register (LROI). J Arthroplasty. 2024;39(7):1758–64. 10.1016/j.arth.2024.01.017. [DOI] [PubMed] [Google Scholar]
- 12.Rhatomy S, Rasyid FA, Phatama KY. The direct anterior approach in total hip arthroplasty: publication trends of Asian countries on pubmed. Ann Med Surg (Lond). 2020;55:280–6. 10.1016/j.amsu.2020.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Ramadanov N, Bueschges S, Liu K, Lazaru P, Marintschev I. Direct and indirect comparisons in network meta-analysis of superpath, direct anterior and posterior approaches in total hip arthroplasty. Sci Rep. 2022;12(1):16778. 10.1038/s41598-022-20242-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Ramadanov N, Bueschges S, Liu K, Lazaru P, Marintschev I. Direct anterior approach vs. SuperPATH vs. conventional approaches in total hip replacement: A network meta-analysis of randomized controlled trials. Orthop Traumatol Surg Res. 2021;107(8):103058. 10.1016/j.otsr.2021.103058. [DOI] [PubMed] [Google Scholar]
- 15.Putananon C, Tuchinda H, Arirachakaran A, Wongsak S, Narinsorasak T, Kongtharvonskul J. Comparison of direct anterior, lateral, posterior and posterior-2 approaches in total hip arthroplasty: network meta-analysis. Eur J Orthop Surg Traumatol. 2018;28(2):255–67. 10.1007/s00590-017-2046-1. [DOI] [PubMed] [Google Scholar]
- 16.Ramadanov N, Bueschges S, Lazaru P, Dimitrov D. A meta-analysis on RCTs of direct anterior and conventional approaches in total hip arthroplasty. Sci Rep. 2021;11(1):20991. 10.1038/s41598-021-00405-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wang Z, Bao HW, Hou JZ. Direct anterior versus lateral approaches for clinical outcomes after total hip arthroplasty: a meta-analysis. J Orthop Surg Res. 2019;14(1):63. 10.1186/s13018-019-1095-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wang K, Zhang T, Xia R, Wang J, Yu J, Wang W. Efficacy of direct anterior approach versus posterolateral approach in total hip arthroplasty: a systematic review and meta-analysis. Arch Orthop Trauma Surg. 2024;144(9):4443–53. 10.1007/s00402-024-05547-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Kucukdurmaz F, Sukeik M, Parvizi J. A meta-analysis comparing the direct anterior with other approaches in primary total hip arthroplasty. Surgeon. 2019;17(5):291–9. 10.1016/j.surge.2018.09.001. [DOI] [PubMed] [Google Scholar]
- 20.Yue C, Kang P, Pei F. Comparison of direct anterior and lateral approaches in total hip arthroplasty: A systematic review and Meta-Analysis (PRISMA). Med (Baltim). 2015;94(50):e2126. 10.1097/md.0000000000002126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Higgins BT, Barlow DR, Heagerty NE, Lin TJ. Anterior vs. posterior approach for total hip arthroplasty, a systematic review and meta-analysis. J Arthroplasty. 2015;30(3):419–34. 10.1016/j.arth.2014.10.020. [DOI] [PubMed] [Google Scholar]
- 22.Barrett WP, Turner SE, Leopold JP. Prospective randomized study of direct anterior vs Postero-Lateral approach for total hip arthroplasty. J Arthroplasty. 2013;28(9):1634–8. 10.1016/j.arth.2013.01.034. [DOI] [PubMed] [Google Scholar]
- 23.Rodriguez JA, Deshmukh AJ, Rathod PA, et al. Does the direct anterior approach in THA offer faster rehabilitation and comparable safety to the posterior approach? Clin Orthop Relat Res. 2014;472(2):455–63. 10.1007/s11999-013-3231-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Christensen CP, Jacobs CA. Comparison of patient function during the first six weeks after direct anterior or posterior total hip arthroplasty (THA): A randomized study. J Arthroplasty. 2015;30(9):94–7. 10.1016/j.arth.2014.12.038. [DOI] [PubMed] [Google Scholar]
- 25.De Serralta-Gomis A-DB, Lizaur-Utrilla J, Benavidez A, Anacleto Lopez-Prats E. No differences between direct anterior and lateral approach for primary total hip arthroplasty related to muscle damage or functional outcome. Int Orthop. 2016;40(10):2025–30. 10.1007/s00264-015-3108-9. [DOI] [PubMed] [Google Scholar]
- 26.Luo ZL, Chen M, Shang XF, et al. Direct anterior approach versus posterolateral approach for total hip arthroplasty in the lateral decubitus position. Zhonghua Yi Xue Za Zhi. 2016;96(35):2807–12. 10.3760/cma.j.issn.0376-2491.2016.35.009. [DOI] [PubMed] [Google Scholar]
- 27.Rykov K, Reininga IHF, Sietsma MS, Knobben BAS, ten Have BLEF. Posterolateral vs direct anterior approach in total hip arthroplasty (POLADA Trial): A Randomized Controlled Trial to Assess Differences in Serum Markers. J Arthroplasty. 2017;32(12):3652–. 10.1016/j.arth.2017.07.008. [DOI] [PubMed] [Google Scholar]
- 28.Zhao H-Y, Kang P-D, Xia Y-Y, Shi X-J, Nie Y, Pei F-X. Comparison of early functional recovery after total hip arthroplasty using a direct anterior or posterolateral approach: A randomized controlled trial. J Arthroplasty. 2017;32(11):3421–8. 10.1016/j.arth.2017.05.056. [DOI] [PubMed] [Google Scholar]
- 29.Zomar BO, Bryant D, Hunter S, Howard JL, Vasarhelyi EM, Lanting BA. A randomised trial comparing spatio-temporal gait parameters after total hip arthroplasty between the direct anterior and direct lateral surgical approaches. Hip Int. 2018;28(5):478–84. 10.1177/1120700018760262. [DOI] [PubMed] [Google Scholar]
- 30.Bon G, Kacem EB, Lepretre PM, et al. Does the direct anterior approach allow earlier recovery of walking following total hip arthroplasty? A randomized prospective trial using accelerometry. Orthop Traumatol Surg Res. 2019;105(3):445–52. 10.1016/j.otsr.2019.02.008. [DOI] [PubMed] [Google Scholar]
- 31.Mjaaland KE, Kivle K, Svenningsen S, Nordsletten L. Do postoperative results differ in a randomized trial between a direct anterior and a direct lateral approach in THA? Clin Orthop Relat Res. 2019;477(1):145–55. 10.1097/corr.0000000000000439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Moerenhout K, Derome P, Laflamme GY, Leduc S, Gaspard HS, Benoit B. Direct anterior versus posterior approach for total hip arthroplasty: a multicentre, prospective, randomized clinical trial. Can J Surg. 2020;63(5):E412–7. 10.1503/cjs.012019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Cao J, Zhou Y, Xin W, et al. Natural outcome of hemoglobin and functional recovery after the direct anterior versus the posterolateral approach for total hip arthroplasty: a randomized study. J Orthop Surg Res. 2020;15(1). 10.1186/s13018-020-01716-4. [DOI] [PMC free article] [PubMed]
- 34.Iorio R, Viglietta E, Mazza D, et al. Do serum markers correlate with invasiveness of the procedure in THA? A prospective randomized study comparing direct anterior and lateral approaches. Orthop Traumatology-Surgery Res. 2021;107(8). 10.1016/j.otsr.2021.102937. [DOI] [PubMed]
- 35.Nambiar M, Cheng TE, Onggo JR, et al. No difference in functional, radiographic, and survivorship outcomes between direct anterior or posterior approach THA: 5-Year results of a randomized trial. Clin Orthop Relat Res. 2021;479(12):2621–9. 10.1097/corr.0000000000001855. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Zhang Q, Yu Y, Zhou J, Teng X, Ren G. Clinical effects comparison of total hip arthroplasty with different approaches for treatment of femoral head necrosis. Chin J Joint Surgery(Electronic Version). 2021;15(2):157–62. [Google Scholar]
- 37.Yunchun P, Hongjun W, Guoqing R, Qiliang Z. Comparison of gait and hip ambulation ability after total hip arthroplasty through different approaches. Chin J Tissue Eng Res. 2024;28(18):2846–51. 10.12307/2024.034. [Google Scholar]
- 38.Hoseth JM, Aae TF, Lian Ø, Myklebust T, Husby OS. Direct anterior and direct lateral approach in patients with femoral neck fractures receiving a total hip arthroplasty: a randomized controlled trial. Acta Orthop. 2025;96:73–9. 10.2340/17453674.2025.42847. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Wu Z, Zheng Y, Zhang X. Safety and efficacy of orthopedic robots in total hip arthroplasty: a network meta-analysis and systematic review. J Orthop Surg Res. 2024;19(1):846. 10.1186/s13018-024-05279-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Llombart-Blanco R, Mariscal G, Barrios C, Vera P, Llombart-Ais R. MAKO robot-assisted total hip arthroplasty: a comprehensive meta-analysis of efficacy and safety outcomes. J Orthop Surg Res. 2024;19(1):698. 10.1186/s13018-024-05199-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Peters RM, Ten Have B, Rykov K, et al. The learning curve of the direct anterior approach is 100 cases: an analysis based on 15,875 total hip arthroplasties in the Dutch arthroplasty register. Acta Orthop. 2022;93:775–82. 10.2340/17453674.2022.4802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Nairn L, Gyemi L, Gouveia K, Ekhtiari S, Khanna V. The learning curve for the direct anterior total hip arthroplasty: a systematic review. Int Orthop. 2021;45(8):1971–82. 10.1007/s00264-021-04986-7. [DOI] [PubMed] [Google Scholar]
- 43.Berg AR, Held MB, Jiao B, et al. Is the direct anterior approach to THA Cost-effective? A Markov analysis. Clin Orthop Relat Res. 2022;480(8):1518–32. 10.1097/corr.0000000000002165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Kamath AF, Chitnis AS, Holy C, et al. Medical resource utilization and costs for total hip arthroplasty: benchmarking an anterior approach technique in the medicare population. J Med Econ. 2018;21(2):218–24. 10.1080/13696998.2017.1393428. [DOI] [PubMed] [Google Scholar]
- 45.Bhargava T, Goytia RN, Jones LC, Hungerford MW. Lateral femoral cutaneous nerve impairment after direct anterior approach for total hip arthroplasty. Orthopedics. 2010;33(7):472. 10.3928/01477447-20100526-05. [DOI] [PubMed] [Google Scholar]
- 46.Shang J, Wang L, Gong J, et al. Low molecular weight heparin dosing regimens after total joint arthroplasty: a prospective, single-center, randomized, double-blind study. J Orthop Surg Res. 2024;19(1):799. 10.1186/s13018-024-05303-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Mirghaderi P, Pahlevan-Fallahy MT, Rahimzadeh P, et al. Low-versus high-dose aspirin for venous thromboembolic prophylaxis after total joint arthroplasty: a systematic review and meta-analysis. J Orthop Surg Res. 2024;19(1):848. 10.1186/s13018-024-05356-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Hartford JM, Knowles SB. Risk factors for perioperative femoral fractures: cementless femoral implants and the direct anterior approach using a fracture table. J Arthroplasty. 2016;31(9):2013–8. 10.1016/j.arth.2016.02.045. [DOI] [PubMed] [Google Scholar]
- 49.Jewett BA, Collis DK. High complication rate with anterior total hip arthroplasties on a fracture table. Clin Orthop Relat Res. 2011;469(2):503–7. 10.1007/s11999-010-1568-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Matta JM, Shahrdar C, Ferguson T. Single-incision anterior approach for total hip arthroplasty on an orthopaedic table. Clin Orthop Relat Res. 2005;441:115–24. 10.1097/01.blo.0000194309.70518.cb. [DOI] [PubMed] [Google Scholar]
- 51.Wang Z, Hou JZ, Wu CH, et al. A systematic review and meta-analysis of direct anterior approach versus posterior approach in total hip arthroplasty. J Orthop Surg Res. 2018;13(1):229. 10.1186/s13018-018-0929-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Miller LE, Gondusky JS, Bhattacharyya S, Kamath AF, Boettner F, Wright J. Does surgical approach affect outcomes in total hip arthroplasty through 90 days of Follow-Up? A systematic review with Meta-Analysis. J Arthroplasty. 2018;33(4):1296–302. 10.1016/j.arth.2017.11.011. [DOI] [PubMed] [Google Scholar]
- 53.Salmons HI, Larson DR, Couch CG, et al. Surgical approach and body mass index impact risk of wound complications following total hip arthroplasty. J Arthroplasty. 2024;39(9s2):S459. 10.1016/j.arth.2024.03.047. [DOI] [PubMed] [Google Scholar]
- 54.Acuña AJ, Do MT, Samuel LT, Grits D, Otero JE, Kamath AF. Periprosthetic joint infection rates across primary total hip arthroplasty surgical approaches: a systematic review and meta-analysis of 653,633 procedures. Arch Orthop Trauma Surg. 2022;142(10):2965–77. 10.1007/s00402-021-04186-3. [DOI] [PubMed] [Google Scholar]
- 55.O’Connor CM, Anoushiravani AA, Acosta E, Davidovitch RI, Tetreault MW. Direct anterior approach total hip arthroplasty is not associated with increased infection rates: A systematic review and Meta-Analysis. JBJS Rev. 2021;9(1):e20. 10.2106/jbjs.Rvw.20.00047. [DOI] [PubMed] [Google Scholar]
- 56.Horberg JV, Coobs BR, Jiwanlal AK, Betzle CJ, Capps SG, Moskal JT. Dislocation rates following total hip arthroplasty via the direct anterior approach in a consecutive, non-selective cohort. Bone Joint J. 2021;103–b(7 Supple B):38–45. 10.1302/0301-620x.103b7.Bjj-2020-2297.R1. [DOI] [PubMed]
- 57.Ang JJM, Onggo JR, Stokes CM, Ambikaipalan A. Comparing direct anterior approach versus posterior approach or lateral approach in total hip arthroplasty: a systematic review and meta-analysis. Eur J Orthop Surg Traumatol. 2023;33(7):2773–92. 10.1007/s00590-023-03528-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Li HX, Zhang QY, Sheng N, Xie HQ. Correlation and diagnostic performance of metal ions in patients with pseudotumor after mom hip arthroplasty: a systematic review and meta-analysis. J Orthop Surg Res. 2024;19(1):723. 10.1186/s13018-024-05198-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Ramadanov N, Voss M, Diallo RM, et al. Do Meta-Analyses of total hip arthroplasty produce reliable results?? A systematic review and Meta-Epidemiological study of statistical methods. Orthop Surg. 2025;17(7):1936–55. 10.1111/os.70077. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
No datasets were generated or analysed during the current study.









